152 related articles for article (PubMed ID: 1479585)
1. N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
Ruckdeschel JC; Modi SP; el-Hamouly W; Portuese E; Archer S
J Med Chem; 1992 Dec; 35(26):4854-7. PubMed ID: 1479585
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structure, and cytostatic properties of new olivacine derivatives.
Jasztold-Howorko R; Croisy A; Carrez D; Jaroszewicz I; Nasulewicz A; Pełczyńska M; Opolski A
Arch Pharm (Weinheim); 2004 Nov; 337(11):599-604. PubMed ID: 15543533
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 9-hydroxy-5-methyl-(and 5,6-dimethyl)-6H-pyrido[4,3-b]carbazole-1-N- [(dialkylamino)alkyl]carboxamides, a new promising series of antitumor olivacine derivatives.
Jasztold-Howorko R; Landras C; Pierré A; Atassi G; Guilbaud N; Kraus-Berthier L; Léonce S; Rolland Y; Prost JF; Bisagni E
J Med Chem; 1994 Jul; 37(15):2445-52. PubMed ID: 8057291
[TBL] [Abstract][Full Text] [Related]
4. In vitro cytotoxicity of S16020-2, a new olivacine derivative.
Léonce S; Perez V; Casabianca-Pignede MR; Anstett M; Bisagni E; Pierré A; Atassi G
Invest New Drugs; 1996; 14(2):169-80. PubMed ID: 8913838
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.
Multon E; Riou JF; LeFevre D; Ahomadegbe JC; Riou G
Biochem Pharmacol; 1989 Jul; 38(13):2077-86. PubMed ID: 2544183
[TBL] [Abstract][Full Text] [Related]
6. New pyridocarbazole derivatives. Synthesis and their in vitro anticancer activity.
Jasztold-Howorko R; Tylińska B; Biaduń B; Gebarowski T; Gasiorowski K
Acta Pol Pharm; 2013; 70(5):823-32. PubMed ID: 24147360
[TBL] [Abstract][Full Text] [Related]
7. Ellipticine analogues and related compounds as inhibitors of reverse transcriptase and as inhibitors of the efflux pump.
Sharples D; Hajós G; Riedl Z; Csányi D; Molnár J; Szabó D
Arch Pharm (Weinheim); 2001 Sep; 334(8-9):269-74. PubMed ID: 11688136
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship analysis of new olivacine derivatives.
Tylińska B; Jasztold-Howorko R; Mastalarz H; Kłopotowska D; Filip B; Wietrzyk J
Acta Pol Pharm; 2010; 67(5):495-502. PubMed ID: 20873417
[TBL] [Abstract][Full Text] [Related]
9. Interrelationship between affinity for DNA, cytotoxicity and induction of DNA-breaks in cultured L1210 cells for two series of tricyclic intercalators. Simplified analogues of ellipticine derivatives.
Pierson V; Pierre A; de Cointet P; Nguyen CH; Bisagni E; Gros P
Biochem Pharmacol; 1989 May; 38(9):1395-406. PubMed ID: 2719718
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives.
Ducrocq C; Wendling F; Tourbez-Perrin M; Rivalle C; Tambourin P; Pochon F; Bisagni E; Chermann JC
J Med Chem; 1980 Nov; 23(11):1212-6. PubMed ID: 7452670
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new 1-phenyl-6H-pyrido[4,3-b]carbazole derivatives with potential cytostatic activity.
Tylińska B; Jasztold-Howorko R; Mastalarz H; Szczaurska-Nowak K; Materek P; Wietrzyk J
Acta Pol Pharm; 2011; 68(1):31-7. PubMed ID: 21485699
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Interactions of Selected Olivacine Derivatives with DNA and Topoisomerase II.
Tylińska B; Dobosz A; Spychała J; Cwynar-Zając Ł; Czyżnikowska Ż; Kuźniarski A; Gębarowski T
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445198
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of a series of cytotoxic 2-acyl-1,2-dihydroellipticines which inhibit topoisomerase II.
Devraj R; Jurayj J; Fernandez JA; Barrett JF; Cushman M
Anticancer Drug Des; 1996 Jun; 11(4):311-24. PubMed ID: 8679054
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antitumor activity of novel 2-alkyl-5-methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives.
Mori R; Kato A; Komenoi K; Kurasaki H; Iijima T; Kawagoshi M; Kiran YB; Takeda S; Sakai N; Konakahara T
Eur J Med Chem; 2014 Jul; 82():16-35. PubMed ID: 24863982
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal Exocytosis of Olivacine on the Way to Explain Drug Resistance in Cancer Cells.
Wiatrak B; Gębarowski T; Czwojdziński E; Gąsiorowski K; Tylińska B
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682799
[TBL] [Abstract][Full Text] [Related]
16. 1,5-dimethyl-6H-pyridazino[4,5-b]carbazole, a 3-aza bioisoster of the antitumor alkaloid olivacine.
Haider N; Sotelo E
Chem Pharm Bull (Tokyo); 2002 Nov; 50(11):1479-83. PubMed ID: 12419913
[TBL] [Abstract][Full Text] [Related]
17. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
[TBL] [Abstract][Full Text] [Related]
18. [Syntheses designed to produce 8-amino ellipticine. Synthesis and pharmacological properties of 8-nitro ellipticine].
Gansser C; Lévque X; Plat M; Viel C
Farmaco Sci; 1982 May; 37(5):283-97. PubMed ID: 7095141
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1.
Malonne H; Farinelle S; Decaestecker C; Gordower L; Fontaine J; Chaminade F; Saucier JM; Atassi G; Kiss R
Clin Cancer Res; 2000 Sep; 6(9):3774-82. PubMed ID: 10999772
[TBL] [Abstract][Full Text] [Related]
20. Effect of new olivacine derivatives on p53 protein level.
Gębarowski T; Wiatrak B; Gębczak K; Tylińska B; Gąsiorowski K
Pharmacol Rep; 2020 Feb; 72(1):214-224. PubMed ID: 32016852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]